Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative 68Ga-PSMA-11 PET/CT

Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative 68Ga-PSMA-11 PET/CT

PurposeThis study was designed to investigate the prognostic role of preoperative 68Ga-PSMA-11 PET/CT in predicting biochemical recurrence (BCR) of localized prostate cancer (PCa) after radical prostatectomy (RP).MethodsA total of 77 biopsy-confirmed PCa patients with 68Ga-PSMA-11 PET/CT prior to RP...

Full description

Bibliographic Details
Main Authors:	Xuefeng Qiu, Mengxia Chen, Haoli Yin, Qing Zhang, Haoyang Li, Suhan Guo, Yao Fu, Shiming Zang, Shuyue Ai, Feng Wang, Hongqian Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Oncology
Subjects:	prostate cancer PSMA - prostate specific membrane antigen radical prostatectomy biochemical recurrence (BCR) prediction
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.745530/full

Similar Items

Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer
by: Shiming Zang, et al.
Published: (2022-09-01)

Prediction of T staging in PI-RADS 4–5 prostate cancer by combination of multiparametric MRI and 68Ga-PSMA-11 PET/CT
by: Yuanzhen Ding, et al.
Published: (2023-12-01)

Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates
by: Barak Rosenzweig, et al.
Published: (2022-03-01)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
by: Ann-Kathrin Oehus, et al.
Published: (2020-04-01)

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer
by: Qing Zhang, et al.
Published: (2017-11-01)

177Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians
by: Ting Bu, et al.
Published: (2022-03-01)

Oncological and functional outcomes following robot-assisted laparoscopic radical prostatectomy at a single institution: a minimum 5-year follow-up
by: Jun-Koo Kang, et al.
Published: (2018-12-01)

Application of 68Ga-PSMA-11 and 18F-PSMA-1007 in prostate cancer
by: Hu Siqi, Zhang Yong
Published: (2022-01-01)

Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
by: Catherine Meyer, et al.
Published: (2022-10-01)

A retrospective study to evaluate the effect of preoperative hormonal therapy on continence recovery
by: Yuwen Wang, et al.
Published: (2023-01-01)

High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation
by: Labib Ataur Rahman, et al.
Published: (2019-12-01)

Pattern of Prostate Cancer Recurrence Assessed by <sup>68</sup>Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy
by: Ismaheel O. Lawal, et al.
Published: (2021-08-01)

Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer.
by: Batool Albalooshi, et al.
Published: (2020-01-01)

Total chemical synthesis of PSMA-11: API for 68Ga-PSMA-11 used for prostate cancer diagnosis
by: K.S. Ajish Kumar, et al.
Published: (2021-12-01)

Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with <sup>68</sup>Ga-PSMA PET/CT Features in Primary Staging
by: Luigia Vetrone, et al.
Published: (2023-03-01)

<sup>68</sup>Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy
by: Janice S.H. Tan, et al.
Published: (2019-03-01)

Imageological/Structural Study regarding the Improved Pharmacokinetics by <sup>68</sup>Ga-Labeled PEGylated PSMA Multimer in Prostate Cancer
by: Huihui Zhang, et al.
Published: (2023-04-01)

Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials
by: Junlong Zhuang, et al.
Published: (2023-06-01)

Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators
by: Elke A. van Brandwijk, et al.
Published: (2024-04-01)

<sup>68</sup>Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
by: Finn Edler von Eyben, et al.
Published: (2021-03-01)

Radical Prostatectomy without Prior Biopsy in Patients with High Suspicion of Prostate Cancer Based on Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography: A Prospective Cohort Study
by: Michael Chaloupka, et al.
Published: (2023-02-01)

Does a previous prostate biopsy-related acute bacterial prostatitis affect the results of radical prostatectomy?
by: Hakan Türk, et al.

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy
by: Nina-Sophie Schmidt-Hegemann, et al.
Published: (2017-11-01)

Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
by: Kadir Alper Kucuker, et al.
Published: (2022-08-01)

Early Dutasteride Monotherapy in Patients With Elevated Serum Prostate-Specific Antigen Levels Following Robot-Assisted Radical Prostatectomy
by: Chin-Heng Lu, et al.
Published: (2019-08-01)

Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
by: Else A. Aalbersberg, et al.
Published: (2020-05-01)

Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance
by: Demetrios N. Simopoulos, et al.
Published: (2017-09-01)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No
by: Benjamin T. Ristau, et al.

OPEN RADICAL RETROPUBIC PROSTATECTOMY
by: M. B. Chibichyan
Published: (2018-03-01)

Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
by: Yan-Nan Zhang, et al.
Published: (2022-07-01)

Active Lumbar Spondylodiscitis on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT Mimicking Bone Metastasis
by: Florian Rosar, et al.
Published: (2023-12-01)

Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer
by: Chuanchi Zhou, et al.
Published: (2022-02-01)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes
by: Walter Henriques da Costa, et al.

Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol
by: F. H. E. Staal, et al.
Published: (2022-04-01)

Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy
by: Paola Mapelli, et al.
Published: (2023-09-01)

Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review
by: Naeim Nabian, et al.
Published: (2022-12-01)

Deep learning based on 68Ga-PSMA-11 PET/CT for predicting pathological upgrading in patients with prostate cancer
by: Shiming Zang, et al.
Published: (2024-01-01)

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
by: Kevin H. Leung, et al.
Published: (2022-12-01)

Endoscopic extraperitoneal radical prostatectomy [electronic resource]: laparoscopic and robot-assisted surgery/
by: Stolzenburg, J. -U (Jens-Uwe), $d1964-, et al.
Published: (2007)

Platinum-Based Neoadjuvant Chemotherapy Before Radical Prostatectomy for Locally Advanced Prostate Cancer With Homologous Recombination Deficiency: A Case Report
by: Junlong Zhuang, et al.
Published: (2022-01-01)